These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 24214399)
1. FOXP1 mutations cause intellectual disability and a recognizable phenotype. Le Fevre AK; Taylor S; Malek NH; Horn D; Carr CW; Abdul-Rahman OA; O'Donnell S; Burgess T; Shaw M; Gecz J; Bain N; Fagan K; Hunter MF Am J Med Genet A; 2013 Dec; 161A(12):3166-75. PubMed ID: 24214399 [TBL] [Abstract][Full Text] [Related]
2. Novel FOXP1 pathogenic variants in two Indian subjects with syndromic intellectual disability. Moirangthem A; Phadke SR Am J Med Genet A; 2021 Apr; 185(4):1324-1327. PubMed ID: 33427368 [TBL] [Abstract][Full Text] [Related]
4. Identification and functional characterization of de novo FOXP1 variants provides novel insights into the etiology of neurodevelopmental disorder. Sollis E; Graham SA; Vino A; Froehlich H; Vreeburg M; Dimitropoulou D; Gilissen C; Pfundt R; Rappold GA; Brunner HG; Deriziotis P; Fisher SE Hum Mol Genet; 2016 Feb; 25(3):546-57. PubMed ID: 26647308 [TBL] [Abstract][Full Text] [Related]
5. Characterization of a recurrent missense mutation in the forkhead DNA-binding domain of FOXP1. Johnson TB; Mechels K; Anderson RH; Cain JT; Sturdevant DA; Braddock S; Pinz H; Wilson MA; Landsverk M; Roux KJ; Weimer JM Sci Rep; 2018 Nov; 8(1):16161. PubMed ID: 30385778 [TBL] [Abstract][Full Text] [Related]
9. De novo mutations in FOXP1 in cases with intellectual disability, autism, and language impairment. Hamdan FF; Daoud H; Rochefort D; Piton A; Gauthier J; Langlois M; Foomani G; Dobrzeniecka S; Krebs MO; Joober R; Lafrenière RG; Lacaille JC; Mottron L; Drapeau P; Beauchamp MH; Phillips MS; Fombonne E; Rouleau GA; Michaud JL Am J Hum Genet; 2010 Nov; 87(5):671-8. PubMed ID: 20950788 [TBL] [Abstract][Full Text] [Related]
10. A de novo FOXP1 variant in a patient with autism, intellectual disability and severe speech and language impairment. Lozano R; Vino A; Lozano C; Fisher SE; Deriziotis P Eur J Hum Genet; 2015 Dec; 23(12):1702-7. PubMed ID: 25853299 [TBL] [Abstract][Full Text] [Related]
11. Whole genome sequencing identifies a de novo 2.1 Mb balanced paracentric inversion disrupting FOXP1 and leading to severe intellectual disability. Vuillaume ML; Cogné B; Jeanne M; Boland A; Ung DC; Quinquis D; Besnard T; Deleuze JF; Redon R; Bézieau S; Laumonnier F; Toutain A Clin Chim Acta; 2018 Oct; 485():218-223. PubMed ID: 29969624 [TBL] [Abstract][Full Text] [Related]
12. Assessing the impact of FOXP1 mutations on developmental verbal dyspraxia. Vernes SC; MacDermot KD; Monaco AP; Fisher SE Eur J Hum Genet; 2009 Oct; 17(10):1354-8. PubMed ID: 19352412 [TBL] [Abstract][Full Text] [Related]
13. Three Japanese patients with 3p13 microdeletions involving FOXP1. Yamamoto-Shimojima K; Okamoto N; Matsumura W; Okazaki T; Yamamoto T Brain Dev; 2019 Mar; 41(3):257-262. PubMed ID: 30424912 [TBL] [Abstract][Full Text] [Related]
14. Vocal cord immobility as a cause of aphonia in a child with 3p13p12 deletion syndrome encompassing FOXP1 gene. Mutlu-Albayrak H; Karaer K Int J Pediatr Otorhinolaryngol; 2019 Feb; 117():179-181. PubMed ID: 30579078 [TBL] [Abstract][Full Text] [Related]
15. Identification of FOXP1 deletions in three unrelated patients with mental retardation and significant speech and language deficits. Horn D; Kapeller J; Rivera-Brugués N; Moog U; Lorenz-Depiereux B; Eck S; Hempel M; Wagenstaller J; Gawthrope A; Monaco AP; Bonin M; Riess O; Wohlleber E; Illig T; Bezzina CR; Franke A; Spranger S; Villavicencio-Lorini P; Seifert W; Rosenfeld J; Klopocki E; Rappold GA; Strom TM Hum Mutat; 2010 Nov; 31(11):E1851-60. PubMed ID: 20848658 [TBL] [Abstract][Full Text] [Related]
16. Joint contractures is a recurrent clinical feature of individuals with neurodevelopmental disorder due to FOXP1 likely gene disruptive variants. Peduto C; Cappuccio G; Zeuli R; Zanobio M; Torella A; Alkuraya FS; Joss S; Daolio C; Spinelli AM; Zampieri S; ; Nigro V; Brunetti-Pierri N Am J Med Genet A; 2024 Nov; 194(11):e63713. PubMed ID: 38924631 [TBL] [Abstract][Full Text] [Related]
17. Prospective investigation of FOXP1 syndrome. Siper PM; De Rubeis S; Trelles MDP; Durkin A; Di Marino D; Muratet F; Frank Y; Lozano R; Eichler EE; Kelly M; Beighley J; Gerdts J; Wallace AS; Mefford HC; Bernier RA; Kolevzon A; Buxbaum JD Mol Autism; 2017; 8():57. PubMed ID: 29090079 [TBL] [Abstract][Full Text] [Related]
18. Identification of a Novel Benvenuto M; Palumbo P; Di Muro E; Perrotta CS; Mazza T; Mandarà GML; Palumbo O; Carella M Genes (Basel); 2023 Oct; 14(10):. PubMed ID: 37895307 [TBL] [Abstract][Full Text] [Related]
19. FOXP1 haploinsufficiency: Phenotypes beyond behavior and intellectual disability? Myers A; du Souich C; Yang CL; Borovik L; Mwenifumbo J; Rupps R; Study C; Lehman A; Boerkoel CF Am J Med Genet A; 2017 Dec; 173(12):3172-3181. PubMed ID: 28884888 [TBL] [Abstract][Full Text] [Related]
20. A 785kb deletion of 3p14.1p13, including the FOXP1 gene, associated with speech delay, contractures, hypertonia and blepharophimosis. Pariani MJ; Spencer A; Graham JM; Rimoin DL Eur J Med Genet; 2009; 52(2-3):123-7. PubMed ID: 19332160 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]